Health Condition 1: N90- Other noninflammatory disorders ofvulva and perineum
Conditions
Interventions
Control Intervention1: Intethecal 1%, 2 Chlorprocaine 35mg: Spinal anesthesia will be performed in sitting position at L3-4 or L4-5 interspaces using 25 G whitacre spinal needle. 35mg 1% 2-chlorprocai
Sponsors
Medica Superspecialty Hospital
Eligibility
Inclusion criteria
Inclusion criteria: ASA 1 and 2 patients undergoing short gynecological surgeries under spinal anesthesia lasting less than 60 minutes
Exclusion criteria
Exclusion criteria: 1. Absolute contraindication to spinal anesthesia 2. Neurological diseases 3. Fluid restriction (cardiopulmonary or renal diseases) 4. Allergy or intolerance to local anesthetics
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study and compare the time required to meet eligibility for discharge from the hospital (modified post anaesthetic discharge scoring system) using three doses of 2- chlorprocaine i.e. 35mg, 40mg and 45mg.Timepoint: Sensory and motor blockade will be assessed every 3 mins till readiness of surgery is met and every15 mins for the first 60mins and every 30 mins thereafter till home discharge criteria is met. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To study and compare the efficacy of three doses of 2- chlorprocaine i.e. 35mg, 40mg and 45mg in providing anesthesia for gynecological day care surgery. 2.To study the adverse effects of intrathecal 2- chlorprocaine if any. Timepoint: Heart rate, systolic and diastolic blood pressure and oxygen saturation will be recorded at baseline and immediately after spinal block, every 5 mins for the first 15 mins, every 30mins thereafter till discharge criteria is met. â?¢ 24 hrs after the procedure patient will be interviewed over the telephone for any adverse effects such as headache, vomiting or backache | — |
Countries
India
Contacts
Public ContactJaya Choudhary
Medica Superspecialty Hospital,
Outcome results
None listed